Octavio Ramilo, MD | Source | Chair of the Department of Infectious Diseases at St. Jude Children's Researc...
Octavio Ramilo, MD
A clinician-scientist, Octavio's research focuses on the pathogenesis, effects and treatment of respiratory syncytial virus (RSV), a common and highly contagious virus that especially affects infants and young children. Ramilo has been a member of the NIAID and National Institutes of Health (NIH) Board of Scientific Counselors since 2019, and he lectures internationally about many aspects of infectious disease research. He has also been a member of several NIH review panels and was director of the National Pediatric Infectious Disease Foundation for eight years.
-
St. Jude Children's Research Hospital (https://www.stjude.org/)
Chair of the Department of Infectious Diseases
-
The evolution of RSV disease prevention in infants
Octavio Ramilo, MD, highlights key developments in the effort to prevent RSV disease in recent years, highlights vaccines and monoclonal antibodies.
Article
-
For 60 years, we've been trying to develop new preventive strategies for RSV in children, and it has been very difficult because [of] the immune system of children. We cannot use the traditional vaccine strategy of 2, 4 and 6 months, because, number one, this infection affects the very early in life... even before they can get their routine vaccines. Second, the immune system of infants is immature, so they cannot respond so well to these attempts to do a traditional vaccination.
